Related Experiment Video
Updated: Dec 5, 2025

10:48
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
9.8K
Quantitating Interfraction Target Dynamics During Concurrent Chemoradiation for Glioblastoma: A Prospective Serial
James Stewart1, Arjun Sahgal2, Young Lee3
1Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, Toronto, Canada.
International Journal of Radiation Oncology, Biology, Physics
|October 17, 2020
Summary
Magnetic resonance image (MRI) guided radiation therapy for glioblastoma shows significant tumor changes during treatment. Daily adaptation of radiation plans may improve patient outcomes by accounting for these observed tumor dynamics.
Area of Science:
- Oncology
- Radiotherapy
- Medical Imaging
Background:
- Magnetic resonance image (MRI) guided radiation therapy offers potential for improved glioblastoma treatment outcomes.
- Adapting radiation therapy to real-time tumor changes can enhance treatment efficacy.
Purpose of the Study:
- To quantify interfraction dynamics, including tumor size, position, and geometry, during standard 6-week chemoradiation for glioblastoma.
- To assess temporal changes in gross tumor volumes (GTVs) and clinical target volumes (CTVs) using sequential MRI scans.
Main Methods:
- Prospective imaging of 61 patients using T1-weighted contrast-enhanced and T2/FLAIR sequences at multiple time points during chemoradiation.
- Contouring of GTVs and CTVs at planning, fraction 10, fraction 20, and 1 month post-treatment.
- Quantification of target dynamics using absolute volume, relative volume (Vrel), and migration distance (dmigrate), analyzed with a linear mixed-effects model.
Main Results:
- Median GTV volume significantly decreased from planning scans to 1 month post-treatment (P < .001).
- Significant interfraction migration distances (>5 mm) were observed in over 40% of patients for both GTV and CTV at various treatment points.
- Forty percent of patients showed decreased GTV with significant migration (>5 mm), indicating dynamic tumor changes during therapy.
Conclusions:
- Clinically significant tumor dynamics occur during glioblastoma chemoradiation.
- These findings support the evaluation of daily MRI-guided radiation therapy and adaptive treatment planning for glioblastoma.

